Silo Pharma Achieves Key Milestone with First Dosing in IND-Enabling GLP Study for SPC-15 as a Groundbreaking PTSD Treatment
Preclinical Data to Support Advancement Toward First-in-Human Clinical Trials SARASOTA, FL, March 26, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, ...
New Scientist3h
GLP-1 drugs are only the start – the powerful drugs to expect next
The race is under way to make faster, cheaper and better GLP-1 drugs that will go beyond reducing obesity levels to treating ...
New Scientist3h
What do GLP-1 drugs really tell us about the brain's reward system?
Anecdotal reports suggest drugs like Ozempic may curb not just appetite but also impulsive or addictive behaviour, hinting at ...
Healthcare Dive23h
GLP-1s are accelerating spending growth on traditional drugs, Evernorth research finds
Spending growth for simple medications used to treat common health problems is outstripping spending growth for pricey medications used to treat complex and chronic conditions, according to a new ...
Structure: A Lot Riding On Next Data Readout For Oral GLP-1 Candidate
Despite a crowded GLP-1 drug development field, Structure's oral small molecule approach and strong financial position offer ...
Healio12d
GLP-1 drugs may extend life, graft survival for kidney transplant recipients with diabetes
For kidney transplant recipients with type 2 diabetes, use of glucagon-like peptide-1 receptor agonists was associated with ...
ABC News14d
Compound versions of some weight loss drugs to be restricted
Here are five questions answered about the FDA's decision to halt compounded versions of GLP-1 drugs. The FDA says state-licensed compounding pharmacies must immediately stop making most compound ...
Monthly Prescribing Reference15d
Risk for Specific Hematologic Cancers Down With GLP-1 Receptor Agonist Use in T2DM
HealthDay News — For patients with type 2 diabetes (T2D), glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is associated with a reduced risk for developing hematologic cancers compared ...
Benefits Pro15d
Holistic approach can help employers offer GLP-1 coverage while holding the line on cost
Furthermore, three of the top five drugs driving the net change in cost per member per month were GLP-1 agonists. Despite the high cost of these medications, demand has continued to increase ...
Healio15d
GLP-1 agonists may be protective against hip fracture in patients with type 2 diabetes
other antidiabetic drugs. SAN DIEGO — GLP-1 agonists may be protective against hip fracture when administered for the treatment of type 2 diabetes, according to results presented here.
thecardiologyadvisor.com15d
GLP-1 Receptor Agonists May Have Broader Range of Benefits, Risks
Kidney stones are among the possible risks of GLP-1 use that were not previously known. Glucagon-like peptide 1 receptor agonists (GLP-1RAs) may have a wider range of benefits and risks than what the ...
news.bloomberglaw15d
Kardashian Vitamin Brand Lemme Sued Over GLP-1 Supplement Claims
The market for GLP-1 agonist medications—used to treat diabetes and obesity—has skyrocketed in the last few years, and Lemme is “hoping to cash in on the GLP-1 agonist craze and swindle Americans into ...